DarioHealth Corp DRIO

NAS: DRIO | ISIN: US23725P2092   8/05/2024
1,610 USD (-1,23%)
(-1,23%)   8/05/2024

7 mei 2024 · DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th · Persbericht

25 april 2024 · Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes · Persbericht

18 april 2024 · Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution · Persbericht

10 april 2024 · Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health · Persbericht

2 april 2024 · Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health · Persbericht

28 maart 2024 · DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results · Persbericht

21 maart 2024 · Dariohealth To Report Fourth Quarter 2023 Results On Thursday, March 28Th · Persbericht

12 maart 2024 · New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications · Persbericht

28 februari 2024 · Dariohealth To Participate In The Cowen 43Rd Annual Healthcare Conference · Persbericht

28 februari 2024 · Dariohealth To Participate In The Cowen 43Rd Annual Healthcare Conference · Persbericht

21 februari 2024 · Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions · Persbericht

11 januari 2024 · Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support · Persbericht

5 december 2023 · National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health · Persbericht

2 november 2023 · DarioHealth Reports Third Quarter 2023 Financial and Operating Results · Persbericht

1 november 2023 · Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter · Persbericht

30 oktober 2023 · DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd · Persbericht

17 oktober 2023 · New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes · Persbericht

5 oktober 2023 · Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm · Persbericht

3 oktober 2023 · DarioHealth to Host Investor Day on The Rise of Digital Health · Persbericht

27 september 2023 · Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs · Persbericht

Mijn selecties